[Antiphospholipid antibodies as a cause of adverse pregnancy outcome. Therapeutic approach].
Chernev
T
T
Koleva
R
R
Karag'ozova
Zh
Zh
Chernev
A
A
D000328:Adult; D017152:Antibodies, Antiphospholipid / Q000032:analysis*; D016736:Antiphospholipid Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use; D005260:Female; D005290:Ferric Compounds / Q000627:therapeutic use; D000077605:Ferric Oxide, Saccharated; D005937:Glucaric Acid; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011256:Pregnancy Outcome; D013395:Sucrose / Q000627:therapeutic use
D017152:Antibodies, Antiphospholipid; D005290:Ferric Compounds; D013395:Sucrose; D006493:Heparin; D000077605:Ferric Oxide, Saccharated; D005937:Glucaric Acid; D001241:Aspirin